Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Journal of Neurology
Published in: Journal of Neurology 6/2014

01-06-2014 | Original Communication

Cognitive and autonomic dysfunction in presymptomatic and early Huntington’s disease

Authors: Jan Kobal, Ziva Melik, Ksenija Cankar, Martin Strucl

Published in: Journal of Neurology | Issue 6/2014

Login to get access

Abstract

Huntington’s disease is characterized by disorders of movement, cognition and behavior. Individuals with Huntington’s disease display aberrant changes in the autonomic nervous system that are detected even before the onset of other symptoms. Subtle cognitive dysfunction may start before other clinical manifestations. The aim of the present study was to investigate the autonomic nervous system response to mental arithmetic and the relationship between the autonomic and cognitive/motor function in presymptomatic and early Huntington’s disease. We examined 15 presymptomatic Huntington’s disease gene carriers (PHD), 15 early Huntington’s disease patients (EHD) and 30 healthy controls. PHD and EHD groups were determined according to Unified Huntington’s Disease Rating Scale (UHDRS) motor score. ECG, heart rate, systolic and diastolic blood pressure, and cutaneous laser Doppler flux were measured during rest and during a simple mental arithmetic test. UHDRS cognitive test battery was applied to determine cognitive dysfunction. During mental arithmetic, the heart rate of PHD/EHD increased significantly less than that of controls. Decreased microvascular response to mental arithmetic was found in EHD. Significant correlations for the PHD/EHD group were found between laser Doppler flux response and Symbol Digit Modalities Test score, and between laser Doppler flux response and UHDRS motor score. It seems that central autonomic dysregulation of cardiovascular system in Huntington’s disease goes along with the degeneration of other central neuronal systems. This finding is relevant as it could enable simple and noninvasive testing of disease progression.
Literature
1.
Gutekunst CA, Norflus F, Hersch SM (2002) The neuropathology of Huntington’s disease. In: Bates G, Harper PS, Jones L (eds) Huntington’s disease. Oxford University Press, New York, pp 251–275
2.
Den Heijer JC, Bollen WL, Reulenm JP (1988) Autonomic nervous function in Huntington’s disease. Arch Neurol 45:309–312CrossRef
3.
Kobal J, Meglic B, Mesec A et al (2004) Early sympathetic hyperactivity in Huntington’s disease. Eur J Neurol 11:842–848CrossRefPubMed
4.
Kremer B (2002) Clinical neurology of Huntington’s disease. Diversity in unity, unity in diversity. In: Bates G, Harper PS, Jones L (eds) Huntington’s disease. Oxford University Press, New York, pp 28–61
5.
Kirkwood SC, Siemers E, Hodes ME et al (2000) Subtle changes among presymptomatic carriers of the Huntington’s disease gene. J Neurol Neurosurg Psychiatry 69:773–779PubMedCentralCrossRefPubMed
6.
Begeti F, Tan AYK, Cummins GA et al (2013) The Addenbrooke’s cognitive examination-revised accurately detects cognitive decline in Huntington’s disease. J Neurol 260:2777–2785CrossRefPubMed
7.
Wolf RC, Sambataro F, Vasic N et al (2008) Altered frontostriatal coupling in pre-manifest Huntington’s disease: effects of increasing cognitive load. Eur J Neurol 15:1180–1190CrossRefPubMed
8.
Paulsen JS, Zimbelman JL, Hinton SC et al (2004) fMRI biomarker of early neuronal dysfunction in presymptomatic Huntington’s disease. Am J Neuroradiol 25:1715–1721PubMed
9.
Rosas HD, Salat DH, Lee SY et al (2008) Cerebral cortex and the clinical expression of Huntington’s disease: complexity and heterogeneity. Brain 131:1057–1068PubMedCentralCrossRefPubMed
10.
Rosas HD, Hevelone ND, Zaleta AK et al (2005) Regional cortical thinning in preclinical Huntington disease and its relationship to cognition. Neurology 65:745–747CrossRefPubMed
11.
Wolf RC, Vasic N, Schönfeldt-Lecuona C et al (2007) Dorsolateral prefrontal cortex dysfunction in presymptomatic Huntington’s disease: evidence from event-related fMRI. Brain 130:2845–2857CrossRefPubMed
12.
Aziz NA, Anguelova GV, Marinus J et al (2010) Autonomic symptoms in patients and pre-manifest mutation carriers of Huntington’s disease. Eur J Neurol 17:1068–1074CrossRefPubMed
13.
14.
Kobal J, Melik Z, Cankar K et al (2010) Autonomic dysfunction in presymptomatic and early symptomatic Huntington’s disease. Acta Neurol Scand 121:392–399CrossRefPubMed
15.
Melik Z, Kobal J, Cankar K et al (2012) Microcirculation response to local cooling in patients with Huntington’s disease. J Neurol 295:921–928CrossRef
16.
Bennaroch EE (1993) The central autonomic network: functional organisation, dysfunction and perspective. Mayo Clin Proc 68:988–1001CrossRef
17.
Aylward EH, Nopoulos PC, Ross CA et al (2011) Longitudinal change in regional brain volumes in prodromal Huntington’s disease. J Neurol Neurosurg Psychiatry 82:405–410PubMedCentralCrossRefPubMed
18.
Peckerman A, la Manca JJ, Smith SL (2000) Cardiovascular stress responses and their relation to symptoms of gulf war veterans with fatiguing illness. Psychosom Med 62:509–516CrossRefPubMed
19.
20.
Huntington Study Group (1996) Unified Huntington’s disease rating scale: reliability and consistency. Mov Disord 11:135–142
21.
Yvonne-Tee GB, Rasool AH, Halim AS et al (2006) Noninvasive assessment of cuteneous vascular function in vivo using capillaroscopy, pletismography and Laser-Doppler instruments; its strengths and weaknesses. Clin Hemorheol Microcirc 34:457–473PubMed
22.
Snowden JS, Craufurd D, Thompson J et al (2002) Psychomotor, executive and memory function in preclinical Huntington’s disease. J Clin Exp Neuropsychol 24:133–145CrossRefPubMed
23.
Paulsen JS, Smith MM, Long JD, the PREDICT investigators and coordinators of the Huntington Study Group (2013) Cognitive decline in prodromal Huntington Disease: implications for clinical trials. J Neurol Neurosurg Psychiatry 84:1233–1239CrossRef
24.
The Huntington’s Disease Collaborative Research Group (1993) A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington’s disease chromosomes. Cell 72:971–983CrossRef
25.
Tonkin AL, Frewin DB (2002) Drugs, chemicals and toxins that alter autonomic function. In: Mathias CJ, Bannister R (eds) Autonomic failure. Oxford University Press, Oxford, pp 527–533
26.
Low PA, Pfeiffer MA (1993) Standardization of clinical tests for practice and clinical trials. In: Low PA (ed) Clinical autonomic disorders: evaluation and management. Little Brown, Boston, pp 728–745
27.
Malik M (1996) Heart rate variability: standards of measurement, physiological interpretation, and clinical use. Circulation 93:1043–1065CrossRef
28.
Stein PK, Kleiger RE (1999) Insights from the study of heart rate variability. Annu Rev Med 50:249–261CrossRefPubMed
29.
Parati G, Di Renzo M, Mancia G (2000) How to measure baroreflex sensitivity: from the cardiovascular laboratory to daily life. J Hypertens 18:7–19CrossRefPubMed
30.
Ostergren J, Kahan T, Hjemdahl P et al (1992) Effects of sympatho-adrenal activation on the finger microcirculation in mild hypertension. J Hum Hypertens 6:169–173PubMed
31.
Thomaides TN, Zoukos Y, Chauhuri KR et al (1993) Physiological assessment of aspects of autonomic function in patients secondary progressive multiple sclerosis. J Neurol 240:139–143CrossRefPubMed
32.
Jänig W, Häbler HJ (2003) Neurophysiological analysis of target-related sympathetic pathways—from animal to human: similarities and differences. Acta Physiol Scand 177:255–274CrossRefPubMed
33.
Paulsen JS, Nopopulos PC, Aylward E et al (2010) Striatal and white matter predictors of estimated diagnosis for Huntington disease. Brain Res Bull 82:201–207PubMedCentralCrossRefPubMed
34.
Rosas HD, Reuter M, Doros G et al (2011) A tale of two factors: what determines rate of progression in Huntington disease? A longitudinal MRI study. Mov Disord 26:1691–1697PubMedCentralCrossRefPubMed
35.
Squitieri F, Cannella M, Giallonardo P et al (2001) Onset and pre-onset studies to define the Huntington’s disease natural history. Brain Res Bull 56:233–238CrossRefPubMed
36.
Sprengelmeyer R, Orth M, Müller HP et al (2013) The neuroanatomy of subthreshold depressive symptoms in Huntington’s disease: a combined diffusion tensor imaging (DTI) and voxel-based morphometry (VBM) study. Psychol Med 7:1–12 [Epub ahead of print]
37.
38.
39.
Metadata
Title
Cognitive and autonomic dysfunction in presymptomatic and early Huntington’s disease
Authors
Jan Kobal
Ziva Melik
Ksenija Cankar
Martin Strucl
Publication date
01-06-2014
Publisher
Springer Berlin Heidelberg
Published in
Journal of Neurology / Issue 6/2014
Print ISSN: 0340-5354
Electronic ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-014-7319-6

Other articles of this Issue 6/2014

Journal of Neurology 6/2014 Go to the issue

Letter to the Editors

An unusual cause of acute paraplegia in a 16-year-old dancer

Original Communication

Influence of serum uric acid levels on prognosis and survival in amyotrophic lateral sclerosis: a meta-analysis

Original Communication

Clinical characteristics and functional outcome of patients with West Nile neuroinvasive disease in Serbia

Original Communication

Diagnosis of asymptomatic natalizumab-associated PML: are we between a rock and a hard place?

Letter to the Editors

Leptomeningeal lymphomatosis from large granular lymphocyte leukaemia

Letter to the Editors

Transient and permanent neuroimaging abnormalities due to partial status epilepticus in a patient with corpus callosum agenesis